[Federal Register Volume 88, Number 193 (Friday, October 6, 2023)]
[Notices]
[Pages 69634-69635]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22311]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis (ACET)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with regulatory provisions, the Centers for 
Disease Control and Prevention (CDC) announces the following meeting of 
the Advisory Council for the Elimination of Tuberculosis Meeting 
(ACET). This meeting is open to the public, limited only by the number 
of audio and web conference lines (1,000 audio and web conference lines 
are available). Time will be available for the public.

DATES: The meeting will be held on December 12, 2023, from 9:30 a.m. to 
4:30 p.m., EST, and December 13, 2023, from 10 a.m. to 12 p.m., EST.
    Written comments must be submitted by December 5, 2023. 
Registration to make oral comments must be submitted by December 5, 
2023.

ADDRESSES: The telephone access number is 1-669-254-5252, Webinar ID: 
Webinar ID: 160 466 2283, and the Passcode is 07266459. The web 
conference access is https://cdc.zoomgov.com/j/1604662283?pwd=czhoNzVrb1BYTHV0bzc0R1hFSml0UT09 Passcode: Xu0wFVH*. The 
number of available audio and web conference lines is 1,000.

FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management 
Lead, Office of Policy, Planning, and Partnerships, National Center for 
HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, Mailstop H24-6, Atlanta, 
GA 30329-4027, Telephone: (404) 639-3423; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Advisory Council for the Elimination of Tuberculosis 
(ACET) advises and makes recommendations regarding the elimination of 
tuberculosis (TB) to the Secretary of Health and Human Services, the 
Assistant Secretary for Health, and the Director, Centers for Disease 
Control and Prevention (CDC). Specifically, the Council makes 
recommendations regarding policies, strategies, objectives, and 
priorities; addresses the development and application of new 
technologies; provides guidance and review of CDC's Tuberculosis 
Prevention Research portfolio and program priorities; and reviews the 
extent to which progress has been made toward eliminating TB.
    Matters to be Considered: The agenda will include discussions on: 
(1) data modernization initiative: DTBE priorities and activities; (2) 
NCHHSTP dataset and standardized variables; (3) TB Elimination 
Alliance: Community Engagement; and (4) updates from the American 
Thoracic Society; CDC; the Infectious Disease Society of America, and 
the European Respiratory Society on treatment guidelines. Agenda items 
are subject to change as priorities dictate.

Public Participation

    Written Public Comment: Members of the public are welcome to submit 
written comments in advance of the meeting. Written comments must be 
submitted by emailing [email protected] with the subject line 
``ACET December 2023 Public Comment Registration'' by December 5, 2023.
    Oral Public Comment: Individuals who would like to make an oral 
comment during the public comment period must register by emailing 
[email protected] with subject line ``ACET December 2023 Public 
Comment Registration'' by December 5, 2023. The public comment period 
is on December 13, 2023, at 10:15 a.m., EST.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and

[[Page 69635]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-22311 Filed 10-5-23; 8:45 am]
BILLING CODE 4163-18-P